JP2022524446A5 - - Google Patents
Info
- Publication number
- JP2022524446A5 JP2022524446A5 JP2021554738A JP2021554738A JP2022524446A5 JP 2022524446 A5 JP2022524446 A5 JP 2022524446A5 JP 2021554738 A JP2021554738 A JP 2021554738A JP 2021554738 A JP2021554738 A JP 2021554738A JP 2022524446 A5 JP2022524446 A5 JP 2022524446A5
- Authority
- JP
- Japan
- Prior art keywords
- insulin
- patient
- preparation
- bloodstream
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962818053P | 2019-03-13 | 2019-03-13 | |
| US62/818,053 | 2019-03-13 | ||
| US201962820174P | 2019-03-18 | 2019-03-18 | |
| US62/820,174 | 2019-03-18 | ||
| PCT/US2020/022496 WO2020186121A1 (en) | 2019-03-13 | 2020-03-12 | Therapeutic agent preparations and methods for drug delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022524446A JP2022524446A (ja) | 2022-05-02 |
| JP2022524446A5 true JP2022524446A5 (cg-RX-API-DMAC7.html) | 2023-03-14 |
Family
ID=72424820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021554738A Pending JP2022524446A (ja) | 2019-03-13 | 2020-03-12 | 嚥下可能な薬物送達デバイスを使用する腸管の内腔への薬物送達のための治療薬調製物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20200289620A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3937971A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022524446A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210138646A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113784724A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020237517A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021017993A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3133086A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021011047A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020186121A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8759284B2 (en) | 2009-12-24 | 2014-06-24 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8734429B2 (en) | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US9402806B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9259386B2 (en) | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9415004B2 (en) | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10689460B2 (en) | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| JP7370974B2 (ja) * | 2017-11-07 | 2023-10-30 | ラニ セラピューティクス， エルエルシー | 嚥下可能薬物送達デバイスを使用する腸管組織への送達のための凝固因子調製物 |
| CN112451500B (zh) * | 2020-12-18 | 2022-05-17 | 南京鼓楼医院 | 一种磁响应载药微针机器人及其制备方法和应用 |
| WO2025081168A1 (en) * | 2023-10-12 | 2025-04-17 | The Brigham And Women's Hospital, Inc. | An intra-abdominal injection system |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8759284B2 (en) * | 2009-12-24 | 2014-06-24 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9283179B2 (en) * | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9629799B2 (en) * | 2010-12-23 | 2017-04-25 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10639272B2 (en) * | 2010-12-23 | 2020-05-05 | Rani Therapeutics, Llc | Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9402807B2 (en) * | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9402806B2 (en) * | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9284367B2 (en) * | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8809269B2 (en) * | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9149617B2 (en) * | 2010-12-23 | 2015-10-06 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US8980822B2 (en) * | 2010-12-23 | 2015-03-17 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9415004B2 (en) * | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8734429B2 (en) * | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US9259386B2 (en) * | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8969293B2 (en) * | 2010-12-23 | 2015-03-03 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9861683B2 (en) * | 2010-12-23 | 2018-01-09 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10689460B2 (en) * | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US20230374155A1 (en) * | 2014-05-15 | 2023-11-23 | Rani Therapeutics, Llc | Pcsk9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US11548940B2 (en) * | 2014-05-15 | 2023-01-10 | Rani Therapeutics, Llc | Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10220076B2 (en) * | 2014-05-15 | 2019-03-05 | Incube Labs, Llc | Pharmaceutical compositions and methods for fabrication of solid masses comprising glucose regulating proteins |
| CN113546036A (zh) * | 2015-05-01 | 2021-10-26 | 拉尼医疗有限公司 | 药物组合物和用于制备包含多肽和/或蛋白质的固体块的方法 |
| CA2993215C (en) * | 2015-07-02 | 2023-10-31 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| JP7370974B2 (ja) * | 2017-11-07 | 2023-10-30 | ラニ セラピューティクス， エルエルシー | 嚥下可能薬物送達デバイスを使用する腸管組織への送達のための凝固因子調製物 |
| CA3032150A1 (en) * | 2018-01-31 | 2019-07-31 | Spectrum Brands, Inc. | Field-handable gate latch |
| US20200206132A1 (en) * | 2018-12-31 | 2020-07-02 | Incube Labs, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| KR20220004148A (ko) * | 2019-05-03 | 2022-01-11 | 라니 테라퓨틱스, 엘엘씨 | 삼킬 수 있는 약물 전달 장치를 사용하여 장관 조직으로 전달하기 위한 응고인자 제제 |
-
2020
- 2020-03-12 BR BR112021017993A patent/BR112021017993A2/pt unknown
- 2020-03-12 JP JP2021554738A patent/JP2022524446A/ja active Pending
- 2020-03-12 KR KR1020217032196A patent/KR20210138646A/ko not_active Abandoned
- 2020-03-12 EP EP20770263.0A patent/EP3937971A4/en not_active Withdrawn
- 2020-03-12 US US16/817,490 patent/US20200289620A1/en not_active Abandoned
- 2020-03-12 WO PCT/US2020/022496 patent/WO2020186121A1/en not_active Ceased
- 2020-03-12 AU AU2020237517A patent/AU2020237517A1/en not_active Abandoned
- 2020-03-12 CN CN202080028733.XA patent/CN113784724A/zh active Pending
- 2020-03-12 MX MX2021011047A patent/MX2021011047A/es unknown
- 2020-03-12 CA CA3133086A patent/CA3133086A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022524446A5 (cg-RX-API-DMAC7.html) | ||
| US20250064796A1 (en) | Abuse-resistant mucoadhesive devices for delivery of buprenorphine | |
| Illum | Nasal drug delivery—Recent developments and future prospects | |
| JP2020058871A5 (cg-RX-API-DMAC7.html) | ||
| Mohammadi et al. | Bacterial cellulose-based composites as vehicles for dermal and transdermal drug delivery: a review | |
| Liu et al. | Stimuli-responsive polymer microneedles: A rising transdermal drug delivery system and Its applications in biomedical | |
| JP2022530615A5 (cg-RX-API-DMAC7.html) | ||
| KR20120008058A (ko) | 설하용 덱스메데토미딘 조성물과 그의 사용 방법 | |
| JP2018526403A5 (cg-RX-API-DMAC7.html) | ||
| ZA202201465B (en) | Long-lasting formulation containing rivastigmine, and method for preparing same | |
| US20240366533A1 (en) | Sublingual Epinephrine Tablets | |
| Sallam et al. | Development of Salbutamol Sulphate fast disintegrating sublingual tablets with enhanced bioavailability and improved clinical efficacy for potential treatment of asthma | |
| Bchkol et al. | Review of the Controlled Drug Delivery Method, Dosage Form Categorization, and Therapeutic Impact on the Human Body | |
| WO2014176417A1 (en) | Topical preparation for bypassing gi tract, delivery of therapeutics, and trans-epithelial drug delivery system | |
| CN109496152B (zh) | 癸氧喹酯组合物的肌肉内库存及其预防和治疗的方法 | |
| Mohamed et al. | Updated treatment modalities of Trichinellosis | |
| Ramarao et al. | Drug delivery systems and biopharmaceutical consideration of drug products designs: a review | |
| Simons et al. | Sublingual epinephrine administration in humans: a preliminary study | |
| Hamzy et al. | An in-depth overview of controlled drug delivery systems: Present developments and prospective advancements | |
| Bhalerao et al. | Insulin therapies: Current and future trends | |
| Zakaria et al. | Recent Advances Using Nano-Drug Delivery Systems in the Management of Diabetes Mellitus | |
| Rahman et al. | Insulin delivery: what is new in the queue | |
| PÃDURARU et al. | NEW ORAL DRUG FORMULATIONS | |
| Kumar et al. | AN INTRODUCTION TO ORODISPERSED TABLETS | |
| RU2006142622A (ru) | Способ лечения острого инфаркта миокарда |